Park Place Capital’s Halozyme HALO Stock Holding History

Park Place Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.5K	Sell	594 -6	-1%	-$409	0.01%	434
2026 Q1	$38.8K	Sell	600 -20	-3%	-$1.41K	0.01%	388
2025 Q4	$41.7K	Hold	620	–	–	0.01%	351
2025 Q3	$45.5K	Sell	620 -466	-43%	-$31K	0.01%	344
2025 Q2	$57.5K	Hold	1,086	–	–	0.01%	329
2025 Q1	$69.3K	Buy	1,086 +182	+20%	+$10.6K	0.02%	303
2024 Q4	$43.2K	Sell	904 -451	-33%	-$23.1K	0.01%	374
2024 Q3	$77.6K	Buy	1,355 +1,209	+828%	+$69.3K	0.02%	318
2024 Q2	$7.64K	Hold	146	–	–	﹤0.01%	650
2024 Q1	$5.94K	Hold	146	–	–	﹤0.01%	719
2023 Q4	$5.4K	Hold	146	–	–	﹤0.01%	714
2023 Q3	$5.58K	Hold	146	–	–	﹤0.01%	840
2023 Q2	$5.27K	Hold	146	–	–	﹤0.01%	862
2023 Q1	$5.58K	Hold	146	–	–	﹤0.01%	853
2022 Q4	$8K	Buy	+146	New	+$7.47K	﹤0.01%	792

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Park Place Capital's HALO Position: Q2 2026 in Review

Park Place Capital reduced its Halozyme (HALO) stake by 1% in Q2 2026, selling an estimated $409 and leaving 594 shares worth $46.5K. The position accounts for 0.01% of the portfolio, ranked #434.

Park Place Capital first reported a position in HALO in Q4 2022 and has held it in 15 quarters since. The position peaked at $77.6K in Q3 2024. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Park Place Capital held 594 shares of Halozyme worth $46.5K as of Q2 2026.
Park Place Capital sold 6 Halozyme shares in Q2 2026, an estimated $409.
Halozyme made up 0.01% of Park Place Capital's portfolio in Q2 2026, its #434 holding.
Park Place Capital first reported a position in Halozyme in Q4 2022 and has held it in 15 quarters since.
Park Place Capital's Halozyme position peaked at $77.6K in Q3 2024.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.